MYRIAD GENETICS, INC. Payments to Acquire Other Productive Assets
MYRIAD GENETICS, INC. (MYGN) reported Payments to Acquire Other Productive Assets of $7.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherProductiveAssets · last filed 2026-07-31
- MYRIAD GENETICS, INC. payments to acquire other productive assets for the quarter ending 2026-06-30 was $2.10M, a 25.00% decline year-over-year.
- MYRIAD GENETICS, INC. payments to acquire other productive assets for the quarter ending 2026-03-31 was $5.40M, a 1.89% increase year-over-year.
- MYRIAD GENETICS, INC. payments to acquire other productive assets for the quarter ending 2025-12-31 was $4.70M, a 30.56% increase year-over-year.
- MYRIAD GENETICS, INC. payments to acquire other productive assets for the quarter ending 2025-09-30 was $2.80M, a 20.00% decline year-over-year.
- MYRIAD GENETICS, INC. payments to acquire other productive assets for fiscal 2025 was $15.60M, a 17.89% decline from fiscal 2024.
- MYRIAD GENETICS, INC. payments to acquire other productive assets for fiscal 2024 was $19.00M, a 69.94% decline from fiscal 2023.
- MYRIAD GENETICS, INC. payments to acquire other productive assets for fiscal 2023 was $63.20M, a 39.51% increase from fiscal 2022.
- MYRIAD GENETICS, INC. payments to acquire other productive assets for fiscal 2022 was $45.30M, a 151.67% increase from fiscal 2021.
| Period end | Payments to Acquire Other Productive Assets 3 month | Payments to Acquire Other Productive Assets 6 month | Payments to Acquire Other Productive Assets 9 month | Payments to Acquire Other Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $7.50M 10-Q · filed 2026-07-31 | $12.20M derived: sum of 3 quarters · filed 2026-07-31 | $15.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $5.40M 10-Q · filed 2026-05-06 | $10.10M derived: sum of 2 quarters · filed 2026-05-06 | $12.90M derived: sum of 3 quarters · filed 2026-05-06 | $15.70M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.50M derived: sum of 2 quarters · filed 2026-02-24 | $10.30M derived: sum of 3 quarters · filed 2026-07-31 | $15.60M 10-K · filed 2026-02-24 |
| 2025-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.60M derived: sum of 2 quarters · filed 2026-07-31 | $10.90M 10-Q · filed 2025-11-04 | $14.50M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $8.10M 10-Q · filed 2026-07-31 | $11.70M derived: sum of 3 quarters · filed 2026-07-31 | $15.20M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $5.30M 10-Q · filed 2026-05-06 | $8.90M derived: sum of 2 quarters · filed 2026-05-06 | $12.40M derived: sum of 3 quarters · filed 2026-05-06 | $17.60M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.10M derived: sum of 2 quarters · filed 2026-02-24 | $12.30M derived: sum of 3 quarters · filed 2026-02-24 | $19.00M 10-K · filed 2026-02-24 |
| 2024-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $8.70M derived: sum of 2 quarters · filed 2025-11-04 | $15.40M 10-Q · filed 2025-11-04 | $25.40M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $11.90M 10-Q · filed 2025-08-06 | $21.90M derived: sum of 3 quarters · filed 2026-02-24 | $32.80M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $6.70M 10-Q · filed 2025-05-07 | $16.70M derived: sum of 2 quarters · filed 2026-02-24 | $27.60M derived: sum of 3 quarters · filed 2026-02-24 | $46.40M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $20.90M derived: sum of 2 quarters · filed 2026-02-24 | $39.70M derived: sum of 3 quarters · filed 2026-02-24 | $63.20M 10-K · filed 2026-02-24 |
| 2023-09-30 | $10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $29.70M derived: sum of 2 quarters · filed 2024-11-08 | $53.20M 10-Q · filed 2024-11-08 | $67.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $18.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $42.30M 10-Q · filed 2024-08-07 | $56.90M derived: sum of 3 quarters · filed 2025-02-28 | |
| 2023-03-31 | $23.50M 10-Q · filed 2024-05-08 | $38.10M derived: sum of 2 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $45.30M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $30.70M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $18.00M 10-K · filed 2024-02-28 | |||
| 2012-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $0.00 derived: sum of 2 quarters · filed 2014-08-13 | $100.00K 10-K · filed 2014-08-13 | |
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $100.00K 10-Q · filed 2013-05-08 | ||
| 2011-12-31 | $100.00K 10-Q · filed 2013-02-06 | |||
| 2011-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2013-08-14 | $100.00K 10-K · filed 2013-08-14 | |
| 2011-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-02 | $100.00K 10-Q · filed 2012-05-02 | ||
| 2010-12-31 | $100.00K 10-Q · filed 2012-02-01 | |||
| 2010-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-15 | $0.00 derived: sum of 2 quarters · filed 2012-08-15 | $100.00K 10-K · filed 2012-08-15 | |
| 2010-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-05-04 | $100.00K 10-Q · filed 2011-05-04 | ||
| 2009-12-31 | $100.00K 10-Q · filed 2011-02-01 | |||
| 2009-06-30 | $2.10M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |